Skip to content

SVRA

Savara Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.37
+0.00%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$2.2M
Net value (3m)
+4.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 24, 2026Lutz Robert Matthew · officer: Chief Fin. & Operating OfficerA-Award70,000$5.81
Jul 24, 2026Lutz Robert Matthew · officer: Chief Fin. & Operating OfficerA-Award35,000$0.00
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind53,387$5.50
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt75,000$1.59
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt87,650$3.35
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind11,491$5.50
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt56,937$1.11
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt129,350$1.23
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt218,750$1.51
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind10,114$5.50
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerSale394,528$5.68
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind28,928$5.50
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt12,500$4.45
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind21,682$5.50
Jun 22, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind60,057$5.50
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt12,500$4.45
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt43,063$1.11
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt80,684$1.51
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind23,661$5.04
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind9,485$5.04
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind24,174$5.04
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt75,000$1.59
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind16,518$5.04
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt24,850$3.35
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind11,037$5.04
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerM-Exempt130,650$1.23
Mar 20, 2026Lowrance David L · officer: Chief Financial OfficerF-InKind31,885$5.04
Feb 17, 2026McCracken Joseph S · directorM-Exempt1,807$1.76
Dec 19, 2025RAMSAY DAVID A · directorSale20,000$6.06
Dec 16, 2025Erickson Anne · officer: Chief Business OfficerF-InKind62,960$6.92
Institutional positioning

13F filings over the trailing two quarters

New 61Increased 61Reduced 42Sold out 180
FilerActionSharesFiled
NEA MANAGEMENT COMPANY, LLCUnchanged24,471,264May 15, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCUnchanged17,600,621May 15, 2026
VR ADVISER, LLCUnchanged13,740,375May 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Unchanged13,569,000May 15, 2026
TCG CROSSOVER MANAGEMENT, LLCUnchanged12,362,205May 15, 2026
BLACKROCK, INC.Increased11,291,185May 13, 2026
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Reduced9,720,852May 15, 2026
POLAR CAPITAL HOLDINGS PLCIncreased9,541,786May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position7,783,913May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged7,344,783May 15, 2026
STATE STREET CORPIncreased6,707,684May 15, 2026
RTW INVESTMENTS, LPUnchanged5,952,380May 15, 2026
MARSHALL WACE, LLPReduced4,514,348May 15, 2026
WOODLINE PARTNERS LPIncreased4,245,119May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased3,594,480May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 24, 2026